Hongjie Zhu, Ph.D.
Affiliations: | 2011 | Bioinformatics and Statistics | North Carolina State University, Raleigh, NC |
Area:
Bioinformatics Biology, Biostatistics Biology, Systematic BiologyGoogle:
"Hongjie Zhu"Parents
Sign in to add mentor| Zhaobang Zeng | grad student | 2011 | NCSU | |
| (Pharmacometabolomics Data Analysis and Nonlinear Sufficient Dimension Reduction for Genome-Scale Studies.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bhattacharyya S, Ahmed AT, Arnold M, et al. (2019) Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients. Translational Psychiatry. 9: 173 |
| Liu D, Ray B, Neavin DR, et al. (2018) Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics. Translational Psychiatry. 8: 10 |
| Elbadawi-Sidhu M, Baillie RA, Zhu H, et al. (2017) Pharmacometabolomic signature links simvastatin therapy and insulin resistance. Metabolomics : Open Access. 13 |
| Toledo JB, Arnold M, Kastenmüller G, et al. (2017) Metabolic network failures in Alzheimer's disease-A biochemical road map. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Gupta M, Neavin D, Liu D, et al. (2016) TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics. Molecular Psychiatry |
| Zhu HX, Xue ZQ, Qiu WY, et al. (2015) Age-related intraneuronal accumulation of αII-spectrin breakdown product SBDP120 in the human cerebrum is enhanced in Alzheimer's disease. Experimental Gerontology. 69: 43-52 |
| Krauss RM, Zhu H, Kaddurah-Daouk R. (2013) Pharmacometabolomics of statin response. Clinical Pharmacology and Therapeutics. 94: 562-5 |
| McEvoy J, Baillie RA, Zhu H, et al. (2013) Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. Plos One. 8: e68717 |
| Zhu H, Bogdanov MB, Boyle SH, et al. (2013) Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway. Plos One. 8: e68283 |
| Yerges-Armstrong LM, Ellero-Simatos S, Georgiades A, et al. (2013) Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics. Clinical Pharmacology and Therapeutics. 94: 525-32 |